(Adds detail, background)
By Dietrich Knauth
May 3 (Reuters) - Washington has reached a $518 million
settlement with drug distributors McKesson Corp MCK.N ,
AmerisourceBergen Corp ABC.N and Cardinal Health CAH.N ,
ending a months-long trial over the companies' alleged role in
fueling the opioid epidemic in the state, McKesson announced on
Tuesday.
Washington opted out of a $26 billion nationwide opioid
settlement involving the three drug distributors and Johnson &
Johnson JNJ.N . It would have received up to $417.9 million
from McKesson, Cardinal Health and AmerisourceBergen under that
settlement, which was finalized in February. urn:newsml:reuters.com:*:nL1N2V023E
The state had accused the drug distributors of failing to
prevent prescription pills from being diverted for illegal use.
It had sought $38.2 billion to fund treatment.
The distributors, who deny wrongdoing, said the settlement
would provide meaningful relief to communities impacted by the
opioid epidemic in the United States. Opioid overdoses have
caused more than 500,000 deaths in the United States over the
past two decades, according to the U.S. Centers for Disease
Control and Prevention.
(Reporting by Dietrich Knauth; Editing by Emelia
Sithole-Matarise)
((Dietrich.Knauth@thomsonreuters.com;))